124
M. Mokhtar et al. / Journal of Molecular Catalysis A: Chemical 353–354 (2012) 122–131
2.3. Characterizations of the reaction products
127.94, 129.41, 131.98, 136.59, 146.85, 148.09, 151.49, 155.29,
159.42; MS (m/z): 301(M+).
All melting points were measured on a Gallenkamp melting
point apparatus and are uncorrected. The infrared spectra were
recorded in KB risks on a pyeUnicam SP 3300 and Shimadzu
FTIR 8101 PC infrared spectrophotometers. The NMR spectra were
recorded on a Varian Mercury VX-300 NMR spectrometer. 1H spec-
tra were run at 300 MHz and 13C spectra were run at 75.46 MHz
in deuterated chloroform (CDCl3) or dimethyl sulphoxide (DMSO-
d6). Chemical shifts were related to that of the solvent. Mass
spectra were recorded on a Shimadzu GCMS-QP 1000 EX mass
spectrometer at 70 eV. Elemental analyses (C, H, N, S) were car-
ried out at the Microanalytical Center of Cairo University, Giza,
Egypt, the results were found to be in good agreement ( 0.3%)
with the calculated values. Microwave experiments were carried
out using CEM Discover LabmateTM microwave apparatus (300 W
with ChemDriverTM Software).
2.4.2.4. 2-Methyl-7-(4-flurophenyl)pyrazolo[1,5-a]pyrimidine (3d).
m.p. 135–137 ◦C, IR (KBr) vmax/cm−1: 1601 (C N); 1H NMR (CDCl3):
ı 2.08 (s, 3H, CH3), 6.12 (s, 1H, H-3), 6.89 (d, 2H, J = 4.8 Hz, H-
6), 7.14–7.78 (m, 4H, Ar-H), 8.20 (d, J = 4.8 Hz, 2H, H-5). 13C NMR
(CDCL3): ı 13.11, 92.54, 116.19, 118.23, 118.24, 127.50, 128.18,
128.19, 142.54, 144.17, 148.00, 152.45, 161.12; MS (m/z): 227(M+).
2.4.2.5. 7-(4-Flurophenyl)-2-phenylpyrazolo[1,5-a]pyrimidine (3e).
m.p. 169 ◦C, IR (KBr) vmax/cm−1: 1605 (C N); 1H NMR (CDCl3): ␦
6.39 (d, J = 4.2 Hz, 2H, H-6), 6.99 (s, 1H, H-3), 7.10–8.13 (m, 9H, Ar-
H), 8.51 (d, J = 4.2 Hz, 2H, H-5). 13C NMR (CDCL3): ı 90.52, 116.22,
118.84, 125.62, 125.65, 128.88, 128.94, 129.87, 129.88, 130.14,
130.15, 134.19, 142.62, 144.89, 148.78, 151.44, 161.62; MS (m/z):
289(M+).
2.4. Typical procedure for the catalyst test reaction
2.4.2.6. 7-(4-Flurophenyl)-2-(4-methoxyphenyl)pyrazolo[1,5-
a]pyrimidine (3f). m.p. 186–188 ◦C, IR (KBr) vmax/cm−1: 1601
(C N); 1H NMR (CDCl3): ı 3.89 (s, 3H, OCH3), 6.95 (s, 1H, H-3), 7.16
(d, J = 4.5 Hz, 2H, H-6), 7.25–8.13 (m, 8H, Ar-H), 8.26 (d, J = 4.5 Hz,
2H, H-5). 13C NMR (CDCL3): ı 54.12, 90.12, 113.11, 116.12, 118.15,
118.6, 123.24, 126.00, 128.99, 129.00, 131.98, 142.58, 144.45,
148.98, 151.11, 160.01, 161.59; MS (m/z): 319(M+).
2.4.1. Method A: microwave irradiation
(10 mmol) and one of the 5-amino-1H-pyrazole derivatives (2a–c)
(10 mmol) in a mortar, the mixture was ground with a pestle at
room temperature then placed in an Pyrex tube in the microwave
reactor and irradiated for a suitable time (Table 3) with a 2 min
interval. The progress of the reaction was monitored by TLC. Upon
completion of the reaction, the mixture was cooled and the prod-
uct was extracted by dissolution in hot alcohol after evaporating the
volatile materials by vacuum, compounds 4a–c were re-crystallized
from ethanol. The catalyst used was redeemed by washing with
hot alcohol. Compound 4b was obtained in the presence of vari-
neat conditions under microwave irradiation. It was found that all
catalysts used exhibited catalytic activity but HT-As was the most
effective of all the catalysts tested to promote the reaction with
high yield in short time (Table 2).
3. Results and discussion
3.1. Catalyst characterization
3.1.1. Elemental chemical analysis (ICP)
ICP analysis of HT-As was performed to determine its chemical
composition. The analysis revealed that the Mg/Al molar ratio was
1.8, which is very close to the nominal molar composition of the
pre-calculated Mg/Al molar ratio of 2. This result confirmed the
effectiveness of the precipitation process.
2.4.2. Method B: conventional method
3.1.2. X-ray diffraction (XRD)
These processes were performed on the same scale described
above for method A. Here the reactant and catalyst were put in
ethanol under reflux for 5–8 h (Table 4) until the starting materials
were no longer detectable by TLC. The products were obtained and
purified as described above in method A.
X-ray powder diffraction patterns of as-synthesized hydrotal-
cite (HT-As) are shown in Fig. 2. A phase analysis shows that only
a hydrotalcite layered structure is obtained (Ref. Pattern 22-0700,
JCPDS) with sharp and intense peaks for the (0 0 3), (0 0 6), (0 0 9),
(1 1 0) and (1 1 3) planes and broad peak for the (0 1 5) plane. The
crystal structure of the investigated HT-As was rhombohedral with
R-3m space group. The lattice parameters were calculated and the
average crystallite sizes were estimated from the Scherrer equation
using the FWHM of the basal reflection plane (0 0 3) and the non
basal line (1 1 0). The calculated lattice parameter a, which is mainly
related to the cation composition, was equal to 0.306 nm. The a
value decreases as the Al content increases from the initial value
of the Al-free brucite phase to the synthesized Mg/Al-hydrotalcite
[47]. The calculated cell parameter c, which is directly linked to the
interlayer distance, was equal to 2.34 nm, and the obtained crys-
tallite size was 19 nm. The longer dimension in the c direction is
mainly attributed to the relatively large distance between cation
sheets of hydrotalcites. The calcination of as-synthesized hydrotal-
cite phase at 450 ◦C (HT-450) led to the formation of an amorphous
magnesium oxide phase (periclase: Ref. Pattern 45-0946, JCPDS)
[48,49].
Physical and spectral data of the title compounds 3a–f are listed
below.
2.4.2.1. 2-Methyl-7-phenylpyrazolo[1,5-a]pyrimidine
(3a). m.p.
125 ◦C [lit. [43] m.p. 123–125 ◦C], IR (KBr) vmax/cm−1: 1599 (C N);
1H NMR (CDCl3): ı 2.29 (s, 3H, CH3), 6.28 (s, 1H, H-3), 6.96 (d, 2H,
J = 4.2 Hz, H-6), 6.99–8.01 (m, 5H, Ar-H), 8.33 (d, J = 4.2 Hz, 2H, H-5).
13C NMR (CDCL3): ı 13.71, 92.79, 115.09, 127.54, 128.49, 128.89,
133.45, 143.08, 146.11, 151.34, 157.44; MS (m/z): 209(M+).
2.4.2.2. 2,7-Diphenylpyrazolo[1,5-a]pyrimidine (3b). m.p. 157 ◦C
[lit. [43] m.p. 157 ◦C], IR (KBr) vmax/cm−1: 1601 (C N); 1H NMR
(CDCl3): ı 6.92 (d, J = 5.1 Hz, 2H, H-6), 6.99 (s, 1H, H-3), 7.42–8.24
(m, 10H, Ar-H),), 8.45 (d, J = 5.1 Hz, 2H, H-5). 13C NMR (CDCl3):
ı 91.59, 116.84, 126.45, 126.67, 128.88, 128.94, 129.88, 130.78,
132.00, 132.02, 145.78, 148.15, 151.44, 156.21; MS (m/z): 271(M+).
The liquid phase hydration of calcined hydrotalcite at 450 ◦C
(HT-450-H) did not fully match that of the initial hydrotalcite (HT-
As). The method of hydration of calcined hydrotalcite phase affects
the re-hydrated phase structure. The phase formed after liquid
water hydration of the calcined solid at 450 ◦C is a hydrotalcite-like
phase named meixnerite [49]. These changes in the phase structure
2.4.2.3. 2-(4-Methoxyphenyl)-7-phenylpyrazolo[1,5-a]pyrimidine
(3c). m.p. 172 ◦C, IR (KBr) vmax/cm−1: 1598 (C N); 1H NMR
(CDCl3): ı 3.61 (s, 3H, OCH3), 6.59 (s, 1H, H-3), 7.01 (d, J = 4.2 Hz,
2H, H-6), 7.38–8.01 (m, 9H, Ar-H), 8.33 (d, J = 4.2 Hz, 2H, H-5).
13C NMR (CDCL3): ı 52.80, 95.02, 113.26, 116.84, 126.02, 126.59,